The company aims to provide strategic consulting and operational services in the areas of drug development and positioning, translational, clinical and preclinical research, personalized medicine, biomarker-based patient selection, interaction with health authorities, as well as conducting due diligence in the context of licensing and acquisitions in the pharmaceutical and healthcare sector. It may establish agencies, branches and subsidiaries both domestically and abroad, and generally engage in any activity that is suitable to promote the purpose of the company, including in particular acquiring, managing, encumbering and disposing of participations, real estate and intangible property rights. It may also arrange financing for itself and third parties, as well as provide guarantees and other securities.